Abstract
Abstract Purpose: To study the relationships between CT perfusion parameters and circulating angiogenic factors in patients with hepatocellular carcinoma (HCC) Materials and Methods: This study was HIPAA compliant and was approved by the institutional review board. All participants provided informed consents. CT perfusion parameters of HCCs among 21 patients were assessed using 21-phase liver images at a 64-slice multidetector CT. We analyzed CT perfusion parameters including total blood flow, arterial blood flow, portal blood flow and arterial fraction (arterial blood flow /total blood flow) of HCCs, surrounding liver parenchyma and HCC-parenchyma ratio. Interleukin 6 (IL-6), interleukin 8 (IL-8), vascular endothelial growth factor (VEGF), and platelet derived growth factor (PDGF) in plasma were measured using Bio-Plex multiplex immunoassay in 21 HCC patients and 8 healthy controls. Result: CT perfusion parameters of HCCs showed statistically different from that of surrounding liver parenchyma in total blood flow (p=0.002), portal blood flow (p<0.001) and arterial fraction (p<0.001). Circulating IL-6, IL-8 and VEGF showed significantly higher levels in HCC patients than controls (p<0.05), and predicted HCC significantly better than chance (p<0.001). None of circulating angiogenic factors had significant correlation with any of CT perfusion parameters in HCC patients. Only HCC-parenchyma ratio of arterial blood flow showed significant positive correlation with circulating IL-8 (p<0.05). Conclusion: CT perfusion parameters of HCC and circulating angiogenic factors are useful tools for HCC diagnosis. Only circulating IL-8 and HCC-parenchyma ratio of arterial blood flow showed significant correlation. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 291. doi:10.1158/1538-7445.AM2011-291
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
